Klinische Forschung Karlsruhe GmbH
Karlsruhe, Germany
Research institute in Karlsruhe, Baden-Württemberg
Ettlinger-Tor-Platz 3, 76137 Karlsruhe
About Klinische Forschung Karlsruhe GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Idorsia Pharmaceuticals Ltd.
2
Aboca Spa Societa' Agricola
1
Allergan
1
Asarina Pharma
1
Bayer
1
Inventiva Pharma
1
Clinical Trials at Klinische Forschung Karlsruhe GmbH
During the past decade, Klinische Forschung Karlsruhe GmbH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
2018-06-04
2020-02-25
Completed
930
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
2018-10-09
2021-02-22
Completed
804
A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)
2018-04-20
2020-10-23
Completed
475
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
2021-08-19
2026-09-30
Recruiting
1,000
Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.
2021-08-05
2023-02-15
Completed
71
A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain
2022-02-16
2022-11-21
Completed
80
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinische Forschung Karlsruhe GmbH" #1 sponsor was "Idorsia Pharmaceuticals Ltd." with 2 trials, followed by "Aboca Spa Societa' Agricola" with 1 trials
sponsored, "Allergan" with 1 trials sponsored, "Asarina Pharma" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinische Forschung Karlsruhe GmbH"
#1 collaborator was "Ergomed" with 1 trials as a collaborator, "IQVIA RDS" with 1 trials as a collaborator and "IQVIA Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Klinische Forschung Karlsruhe GmbH
According to Clinical.Site data, the most researched conditions in "Klinische Forschung Karlsruhe GmbH" are
"Insomnia Disorder" (2 trials), "Diabetes Mellitus" (1 trials), "Gastroparesis" (1 trials), "Irritable Bowel Syndrome" (1 trials) and "NASH - Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Klinische Forschung Karlsruhe GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Klinische Forschung Karlsruhe GmbH
Most popular intervention types in "Klinische Forschung Karlsruhe GmbH" are "Drug" (6 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials), "BAY2395840" (1 trials) and "Colilen IBS" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinische Forschung Karlsruhe GmbH
The vast majority of trials in "Klinische Forschung Karlsruhe GmbH" are
6 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Klinische Forschung Karlsruhe GmbH
Currently, there are NaN active trials in "Klinische Forschung Karlsruhe GmbH".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Klinische Forschung Karlsruhe GmbH,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinische Forschung Karlsruhe GmbH, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".